Search results for "SAM"

showing 10 items of 7385 documents

Psychometric properties of non-specific electrodermal response frequency for a sample of male students.

1990

In the present study data on the frequency of non-specific electrodermal responses (NSRs) are presented for a large and, with regard to sex, age and educational level, homogeneous sample of male students (n = 590). These data were obtained in 9 independent experiments in which NSRs were recorded under equivalent conditions. NSRs were scored as skin conductance changes greater than 0.02 muSiemens. A recording period of 5 min prior to experimental manipulations was chosen. A systematic comparison between the 9 studies, the distribution of NSRs for the total sample, as well as descriptive data for stabile and labile subgroups are presented. For 213 subjects NSR-frequency was recorded twice, wi…

AdultMalemedicine.medical_specialtyDescriptive statisticsPsychometricsGeneral NeuroscienceRestScoring criteriaIndividualitySample (statistics)Galvanic Skin ResponseAudiologyReference StandardsDevelopmental psychologyNeuropsychology and Physiological PsychologyNon specificMicrocomputersHomogeneousResearch DesignPhysiology (medical)Electrodermal responsemedicineHumansSkin conductancePsychologyInternational journal of psychophysiology : official journal of the International Organization of Psychophysiology
researchProduct

Is somatosensory amplification a risk factor for an increased report of side effects? Reference data from the German general population

2015

Abstract Objective The study investigates the association between somatosensory amplification and the reporting of side effects. It establishes a German version of the Somatosensory Amplification Scale and examines its psychometric properties in a representative sample of the German population. Methods Sample size was 2.469, with 51% taking any medication. Participants answered the Somatosensory Amplification Scale, Generic Assessment of Side Effects Scale, and indicated whether they were taking any medication and the type of medication. Correlational analysis and binary logistic regression were performed. Results When examining a subsample reporting both medication intake and general bodil…

AdultMalemedicine.medical_specialtyDrug-Related Side Effects and Adverse ReactionsPsychometricsPsychometricsNoceboPopulationAudiologySomatosensory systemLogistic regressionRisk FactorsGermanymedicineHumansRisk factoreducationPsychiatryeducation.field_of_studySomatosensory amplificationSomatosensory CortexMiddle AgedPsychiatry and Mental healthClinical PsychologySample size determinationFemalePsychologyJournal of Psychosomatic Research
researchProduct

NOA-05 phase 2 trial of procarbazine and lomustine therapy in gliomatosis cerebri.

2011

The NOA-05 multicenter trial was performed to analyze the efficacy of primary chemotherapy with procarbazine and lomustine (PC) in patients with gliomatosis cerebri (GC) and to define clinical, imaging, and molecular factors influencing outcome.Thirty-five patients with previously untreated GC were treated with up to six 56-day courses of 110mg/m(2) lomustine on day 1 and 60mg/m(2) procarbazine on days 8 to 21. The primary endpoint was the rate of patients without therapy failure (defined as progressive disease, death from any cause, or termination of PC therapy before the end of course 4) at 8 months after the beginning of PC chemotherapy.The failure-free survival rate at 8 months was 50.3…

AdultMalemedicine.medical_specialtyEndpoint DeterminationGliomatosis cerebriAntineoplastic AgentsGene mutationProcarbazineGastroenterologyDisease-Free SurvivalLomustineInternal medicineMulticenter trialAntineoplastic Combined Chemotherapy ProtocolsBiomarkers TumorMedicineHumansProspective StudiesKarnofsky Performance StatusSurvival rateDNA Modification MethylasesAgedbusiness.industryTumor Suppressor ProteinsHazard ratioBrainLomustineMiddle Agedmedicine.diseasePrognosisCombined Modality TherapyMagnetic Resonance ImagingNeoplasms NeuroepithelialSurvival AnalysisSurgeryDNA Repair EnzymesTreatment OutcomeNeurologyProcarbazineSample SizeDisease ProgressionFemaleNeurology (clinical)businessProgressive diseasemedicine.drugAnnals of neurology
researchProduct

Baseline characteristics and outcome in Romanian patients with Gaucher disease type 1.

2009

Abstract Background/aim To present clinical and genetic characteristics of all Romanian patients with Gaucher disease type 1, in whom specific diagnosis has been confirmed by enzymatic and molecular methods and to analyze their outcome with and without enzymatic replacement therapy (ERT). Patients, methods There are fifty patients (F/M — 1.63/1) with Gaucher disease type 1. Clinical status, haemoglobin, thrombocytes, hepatic/splenic volume, bone mineral density and severity score were assessed at baseline and every six months thereafter. Thirty-nine patients (78%) received imiglucerase (44.4 ± 13.6 U/kg/2 weeks) for 3.1 +/− 1.4 years. Results Based on general prevalence data, our group repr…

AdultMalemedicine.medical_specialtyEvery Six MonthsBone diseaseImigluceraseAdolescentGenotypeDiseaseGastroenterologyYoung AdultInternal medicineGenotypeInternal MedicinemedicineHumansPlateletAge of OnsetChildAllelesBone mineralGaucher Diseasebusiness.industryRomaniaInfantAnemiaMiddle Agedmedicine.diseasePrognosisThrombocytopeniaSurgeryHexosaminidasesChild PreschoolMutationSplenomegalyGlucosylceramidaseFemalebusinessVisceromegalymedicine.drugEuropean journal of internal medicine
researchProduct

Combination therapy with amantadine and interferon in naı̈ve patients with chronic hepatitis C: meta-analysis of individual patient data from six cli…

2003

Abstract Background/Aims In chronic hepatitis C, clinical trials evaluating the efficacy of amantadine (AMA) and interferon (INF) compared to INF monotherapy, have produced conflicting results. We performed a meta-analysis of the individual patient's data from previous studies. Methods Nine hundred and seventy-two patients from six European centres were evaluated by means of individual patient meta-analysis, using mixed models with centres and the centre–treatment interaction fitted as random variables. Results At the end of therapy, virological responses were 38.5% (95% CI 34.1–42.8) after INF and AMA, and 29.5% (95% CI 25.5–33.6) after INF alone (P=0.003). Sustained response occurred in 1…

AdultMalemedicine.medical_specialtyGenotypeCombination therapyHepacivirusAntiviral AgentsGastroenterologymeta-analysilaw.inventionchemistry.chemical_compoundPharmacotherapyRandomized controlled triallawInternal medicineparasitic diseasesAmantadinemedicinechronic hepatitis CHumansAgedRandomized Controlled Trials as TopictherapyDose-Response Relationship DrugHepatologybusiness.industryRibavirinAmantadineAlanine TransaminaseinterferonHepatitis CHepatitis C ChronicMiddle AgedViral Loadrandomized clinical trialmedicine.diseaseClinical trialTreatment OutcomechemistryImmunologyDrug Therapy CombinationFemaleInterferonsbusinessViral loadmedicine.drugJournal of Hepatology
researchProduct

Hepatitis C virus RNA profiles in chronically infected individuals: do they relate to disease activity?

1999

Fluctuations of hepatitis C virus (HCV)-RNA serum levels were monitored in a multicenter study in 76 chronic HCV carriers who had been followed longitudinally without receiving antiviral therapy to assess their relation with the course of liver disease activity. Forty-four patients had normal transaminases over more than 2 years, while 32 additional patients had fluctuating levels. Viral load was measured in serial serum samples prospectively collected for 10 to 12 months in 54 patients and in sera stored yearly up to 8 years in an additional 22 patients. In patients tested monthly, a lesser extent of fluctuations was detected in cases with constantly normal transaminases as compared with t…

AdultMalemedicine.medical_specialtyGenotypeHepatitis C virusHepacivirusViremiaHepacivirusmedicine.disease_causeGastroenterologyAsymptomaticLiver diseaseFlaviviridaeInternal medicinemedicineHumansLongitudinal StudiesViremiaAgedHepatologybiologybusiness.industryAlanine TransaminaseHepatitis C ChronicMiddle Agedmedicine.diseasebiology.organism_classificationLiverImmunologyCarrier StateRNA ViralFemaleViral diseasemedicine.symptombusinessViral loadHepatology (Baltimore, Md.)
researchProduct

Urinary glycosaminoglycans in Graves' ophthalmopathy.

1990

An increased accumulation of glycosaminoglycans (GAG) in retrobulbar tissues has been reported in patients with thyroid eye disease. We examined the quantitative urinary GAG excretion in 101 patients with Graves' ophthalmopathy of different classes, 36 patients with Graves' hyperthyroidism without ophthalmopathy, 14 patients with toxic nodular goitre and 103 control subjects. Glycosaminoglycans were isolated from 24-h urine collections by precipitation with cetylpyridinium chloride and ethanol followed by photometrical quantification of hexuronic acids after reaction with carbazole. In comparison with the control group (15.8, 10.4, 21.6 mg/24 h; median, 25th, 75th percentile) a significant …

AdultMalemedicine.medical_specialtyGoiterAdolescentEndocrinology Diabetes and MetabolismGraves' diseaseUrinary systemUrineGraves' ophthalmopathyExcretionEndocrinologyInternal medicineImmunopathologymedicineHumansAgedGlycosaminoglycansAged 80 and overbusiness.industryThyroidMiddle Agedmedicine.diseaseCombined Modality TherapyGraves DiseaseEndocrinologymedicine.anatomical_structurePrednisoneFemalebusinessGoiter NodularClinical endocrinology
researchProduct

Frequency and dependence on body posture of hallucinations and sleep paralysis in a community sample.

2002

AdultMalemedicine.medical_specialtyHallucinationsBody postureCognitive NeurosciencePostureMEDLINESample (statistics)General MedicineSleep Paralysismedicine.diseaseSampling StudiesBehavioral NeurosciencemedicineHumansFemalePsychiatryPsychologySleep paralysisJournal of sleep research
researchProduct

Rearing style and depressive disorder in adulthood: a controlled study in a Spanish clinical sample

1999

Objective: The aim of this study was to investigate the style of rearing in a sample of depressive patients and compare it with a control group of normal subjects of similar age, sex, and civil status. The hypothesis to verify was that among the depressives the style of rearing is characterised by a deficit in Emotional Warmth and an excess of Rejection and Protection. We analysed whether the severity of the depression – Major Depressive Disorders versus Depressive Disorders Not Otherwise Specified – was associated with differences in the perceived rearing conditions. Design: It was an observational study of the case/control type. There were 50 patients, whose first depressive episode (DSM-…

AdultMalemedicine.medical_specialtyHealth (social science)AdolescentSocial PsychologyEpidemiologyObservationSample (statistics)Social classSeverity of Illness IndexStyle (sociolinguistics)Surveys and QuestionnairesEpidemiologySeverity of illnessmedicineHumansParent-Child RelationsPsychiatryDepression (differential diagnoses)Depressive DisorderParentingNot Otherwise SpecifiedMiddle AgedPsychiatry and Mental healthSpainFemaleObservational studyPsychologySocial Psychiatry and Psychiatric Epidemiology
researchProduct

The Effectiveness of Laser-Assisted Surgical Excision of Leukoplakias and Hyperkeratosis of Oral Mucosa: A Case Series in A Group of Patients

2019

Introduction: In the different branches of dentistry, the use of laser to solve different clinical situations is increasing due to numerous advantages that have been studied in literature since the 70s. Leucoplakia and hyperkeratosis can benefit from laser-assisted treatment. In most cases biopsy sampling, histological examination and, if no malignant cells are present, the follow-up is needed. However, even if the lesion is free of dysplasia patients often ask to eliminate these white spots that are always a cause of concern. Aim: From these numerous requests comes the idea of setting up a laser-assisted protocol as less invasive as possible to be offered to patients. The aim of the study …

AdultMalemedicine.medical_specialtyHealth Toxicology and MutagenesisleucoplakiaHyperkeratosisCirurgia dentallcsh:Medicineoral medicinehyperkeratosis; laser; leucoplakia; oral medicine; oral surgeryArticleNOLesion03 medical and health sciences0302 clinical medicineBiopsymedicineHumansSampling (medicine)Oral mucosaHyperplasiahyperkeratosismedicine.diagnostic_testbusiness.industryMedical recordlcsh:RMouth MucosaPublic Health Environmental and Occupational HealthhyperkeratosiMED/28 - MALATTIE ODONTOSTOMATOLOGICHE030206 dentistryMiddle Agedmedicine.diseaseSurgerylasermedicine.anatomical_structureDysplasiaMED/07 - MICROBIOLOGIA E MICROBIOLOGIA CLINICAFemaleLasers Semiconductormedicine.symptombusinessOral medicineLeukoplakia030215 immunologyoral surgery
researchProduct